BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Business

  Leidos Awarded Subcontract By International SOS Government Services, Inc.

  September 25, 2015

   · 

  3 min read
• Business

  ResMed To Announce First Quarter Fiscal Year 2016 Results

  September 25, 2015

   · 

  2 min read
• Business

  Helix Biopharma Announces Director Resignation

  September 25, 2015

   · 

  1 min read
• Business

  GENFIT: Half-Year Results For 2015

  September 25, 2015

   · 

  5 min read
• Drug Development

  Triphase Accelerator Announces Health Canada Approval To Initiate Marizomib Phase I Study In Recurrent Glioma Patients

  September 25, 2015

   · 

  4 min read
• Janssen-Cilag International NV’s Daratumumab Accepted For Accelerated CHMP Assessment For Treatment Of European Patients With Heavily Pre-Treated Multiple Myeloma

  September 25, 2015

   · 

  9 min read
• Drug Development

  Catabasis Pharmaceuticals, Inc. Pharmaceuticals Will Present CAT-1004, A Potential Disease-Modifying Agent In Development For The Treatment Of Duchenne Muscular Dystrophy, At The World Muscle Society Congress

  September 25, 2015

   · 

  2 min read
• Business

  Merck & Co. To Hold Third-Quarter 2015 Sales And Earnings Conference Call On October 27

  September 25, 2015

   · 

  3 min read
• Biotech Bay

  Jaguar Animal Health Initiates Proof-Of-Concept Study To Evaluate Safety, Tolerability & Efficacy Of Neonorm In Foals

  September 25, 2015

   · 

  5 min read
• Genetown

  Dicerna To Present At The Leerink Partners Rare Disease Roundtable

  September 25, 2015

   · 

  1 min read